Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.56 |
| ▸ | NPY1R | P25929 | 9/20 | 0.56 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.56 |
| ▸ | NPY2R | P49146 | 5/20 | 0.56 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.52 |
| ▸ | CTSL | P07711 | 1/20 | 0.49 |
| ▸ | CTSC | P53634 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14509067 | 0.94 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL3356931 | 0.94 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL14509088 | 0.94 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL3356923 | 0.94 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL13563450 | 0.94 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL22098763 | 0.94 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL5966602 | 0.93 | GNPAT (0.52) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL1711691 | 0.93 | GNPAT (0.52) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL1711701 | 0.93 | GNPAT (0.52) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL29540393 | 0.93 | GNPAT (0.52) | NPY4RNPY1RNPY5RNPY2RKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119060201-A | Chemoenzymatic synthesis of liraglutide, soxhlet Ma Lutai and GLP-1 | 费森尤斯卡比有限公司 | 2024-12-03 | — | — | CN | disclosed |
| CN-111819191-B | Chemoenzymatic synthesis of liraglutide, soxhlet Ma Lutai and GLP-1 | 费森尤斯卡比有限公司 | 2024-08-20 | — | — | CN | disclosed |
| EP-3704143-B1 | CHEMO-ENZYMATIC SYNTHESIS OF LIRAGLUTIDE, SEMAGLUTIDE AND GLP-1 | FRESENIUS KABI IPSUM S R L (IT) | 2023-10-18 | — | — | EP | disclosed |
| EP-1140985-A1 | SUBSTITUTED HETEROCYCLIC ACYL-TRIPEPTIDES USEFUL AS THROMBIN RECEPTOR MODULATORS | Ortho-McNeil Pharmaceutical, Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000035942-A1 | SUBSTITUTED HETEROCYCLIC ACYL-TRIPEPTIDES USEFUL AS THROMBIN RECEPTOR MODULATORS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2000-06-22 | — | — | WO | disclosed |